Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - DEPRECIATION & AMORTIZATION
Depreciation & Amortization KROS - Keros Therapeutics, Inc.
815 K
LAST VALUE
46.84%
2 YEAR CAGR
39.73%
5 YEAR CAGR
0.00%
10 YEAR CAGR